ADPT vs JCI · rev $142.4M vs P/E 44, rev $23.60B
Adaptive Biotechnologies Corp (ADPT) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
ADPT currently screens at market cap $2.69B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the ADPT and JCI stock pages for the full models.
Not investment advice.